INCIDENCE OF PARTIAL RESPONSE TO PROTON PUMP INHIBITORS IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE IN UK PRIMARY CARE

(1) AstraZeneca R&DMölndal, Mölndal, Sweden

(2) Centro Español de Investigació, n Farmacoepidemiológ, Madrid, Spain

(3) Centro Español de Investigació, Farmacoepidemiológica, Madrid, Spain



This item was part of the GORD management session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A86